Opportunity Information: Apply for RFA CA 19 038

The NIH, through the National Cancer Institute (NCI), offered this Funding Opportunity Announcement called "ITCR: innovative algorithms (R21 Clinical Trial Optional)" (RFA-CA-19-038) to support early-stage, exploratory projects that create genuinely new computational methods for cancer research. It uses the R21 mechanism, which is designed for developmental or high-risk, high-reward ideas that may not yet have extensive preliminary data, but do have a strong conceptual foundation and a clear plan for demonstrating feasibility. The overall focus is on biomedical computing, informatics, and data science, with an emphasis on algorithmic innovation rather than building polished software products.

The core goal is to develop novel computational, mathematical, or statistical algorithms and methods that can significantly improve how cancer-related data and knowledge are acquired, managed, analyzed, and shared. The FOA is broad in terms of where the methods can have impact across the cancer research continuum. That includes basic cancer biology, cancer treatment and diagnosis, early detection, risk assessment and prevention, cancer control and epidemiology, and work aimed at understanding or reducing cancer health disparities. In practical terms, projects could involve new approaches for analyzing complex biomedical data, integrating multiple data types, improving inference or prediction, enhancing reproducibility, or enabling better use of large and messy real-world datasets, as long as the main contribution is an innovative algorithmic or methodological advance with clear relevance to cancer.

This opportunity sits within the NCI Informatics Technology for Cancer Research (ITCR) Program, which is structured to move informatics ideas through a development lifecycle in a research-driven way. Within that context, this specific FOA is aimed at the earlier, innovation-heavy part of the pipeline: creating and validating new methods. Applicants were expected to make a convincing case that their proposed algorithm or method is truly novel (not a minor tweak of existing approaches) and to explain why it matters for cancer research, meaning how it would enable new science, improve decision-making, or address an unmet need in the field. The announcement also signals that if a team is mainly looking to do later-stage technology efforts such as building a prototype into a hardened tool, adapting it for widespread use, or doing more product-oriented development, they should look at the companion ITCR FOAs designed for downstream development rather than this one.

The FOA is labeled "Clinical Trial Optional," meaning applicants could propose work that does or does not involve a clinical trial, depending on what is necessary for the algorithmic development and evaluation. The funding instrument is a discretionary grant under the NIH, and the activity category is listed under Education and Health, with CFDA number 93.396.

In terms of funding details provided in the source, the award ceiling is $200,000, and the original closing date listed is 2019-11-20, with a creation date of 2019-03-27. (The "ExpectedAwards" field is present but not filled in within the text you provided.) Even though this is an older FOA, the structure is representative of how ITCR positions algorithm-focused R21 proposals: you are generally expected to propose a methodologically bold idea, show why it is needed in cancer research, define how you will test it on relevant cancer data or use cases, and explain what success would look like at the end of an exploratory project.

Eligibility is broad and includes many types of U.S. organizations and some non-U.S. entities. Eligible applicants listed include state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than higher education institutions); for-profit organizations other than small businesses; small businesses; and other organizations. The FOA also explicitly highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This broad eligibility aligns with the program's interest in drawing algorithm and data science innovation from a wide range of communities and institutional settings, including groups well-positioned to address cancer inequities and disparities through improved data and methods.

Overall, the opportunity is best summarized as a targeted R21 grant for inventing and demonstrating new informatics and data science algorithms that can materially improve cancer research, with success hinging on a clear explanation of novelty, a compelling cancer-relevant use case, and a feasible plan to show the method works well enough to justify later-stage technology development through other ITCR pathways.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "ITCR: innovative algorithms (R21 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396.
  • This funding opportunity was created on 2019-03-27.
  • Applicants must submit their applications by 2019-11-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 19 038

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the name of this funding opportunity?

The Funding Opportunity Announcement (FOA) is titled "ITCR: innovative algorithms (R21 Clinical Trial Optional)" with FOA number RFA-CA-19-038.

Which agency and NIH institute offered this FOA?

This FOA was offered by the NIH through the National Cancer Institute (NCI), within the Informatics Technology for Cancer Research (ITCR) Program.

What is the main purpose of this FOA?

The purpose is to support early-stage, exploratory projects that create genuinely new computational methods for cancer research, with an emphasis on algorithmic or methodological innovation rather than building polished software products.

What grant mechanism does this FOA use?

It uses the NIH R21 mechanism, which is designed for developmental, exploratory, and high-risk/high-reward ideas that may not yet have extensive preliminary data, but do have a strong conceptual foundation and a clear plan to demonstrate feasibility.

What kinds of work are considered a good fit?

Projects that propose novel computational, mathematical, or statistical algorithms and methods that significantly improve how cancer-related data and knowledge are acquired, managed, analyzed, and shared. The key is that the primary contribution is an innovative algorithmic or methodological advance with clear relevance to cancer research.

What scientific areas across cancer research can the proposed methods address?

The FOA is broad across the cancer research continuum, including basic cancer biology, cancer diagnosis and treatment, early detection, risk assessment and prevention, cancer control and epidemiology, and work aimed at understanding or reducing cancer health disparities.

Is this FOA focused on software tools or on algorithms?

The emphasis is on algorithmic innovation and new methods, not on building polished or product-like software. If a team mainly wants to do later-stage work such as hardening a tool or adapting it for widespread use, the FOA indicates they should consider companion ITCR opportunities intended for downstream development.

How novel does the proposed approach need to be?

Applicants were expected to make a convincing case that the algorithm or method is truly novel and not just a minor tweak to existing approaches, and to explain why the innovation matters for cancer research.

What does "Clinical Trial Optional" mean for this FOA?

"Clinical Trial Optional" means applicants could propose work that does or does not involve a clinical trial, depending on what is necessary for algorithm development and evaluation.

What kinds of data or evaluation approaches are implied?

Projects are generally expected to define how the new method will be tested on relevant cancer data or through cancer-relevant use cases, and to explain what feasibility and success would look like by the end of the exploratory project.

What is the broader program context for this FOA?

This FOA is part of the NCI ITCR Program, which is structured to move informatics ideas through a research-driven development lifecycle. This particular FOA targets the earlier, innovation-heavy stage focused on creating and validating new methods.

What type of award is it?

The funding instrument is a discretionary grant under the NIH.

What is the activity category and CFDA number listed for this opportunity?

The activity category is listed under Education and Health, and the CFDA number provided is 93.396.

What is the award ceiling mentioned in the provided information?

The award ceiling listed in the provided source is $200,000.

When was this FOA created and when did it close (based on the provided information)?

The creation date listed is 2019-03-27, and the original closing date listed is 2019-11-20.

Does the provided information state how many awards were expected?

No. The text notes that an "ExpectedAwards" field exists but is not filled in within the information provided.

Who is eligible to apply?

Eligibility is broad and includes many U.S. organization types and some non-U.S. entities. Eligible applicants listed include state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than higher education institutions); for-profit organizations other than small businesses; small businesses; and other organizations.

Are foreign (non-U.S.) organizations eligible?

Yes. The FOA explicitly includes non-domestic (non-U.S.) entities (foreign organizations) among eligible applicants.

Does the FOA highlight any specific institution types or communities?

Yes. It explicitly highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and foreign organizations.

How does this FOA relate to efforts addressing cancer health disparities?

The FOA includes work aimed at understanding or reducing cancer health disparities within its scope, and the broad eligibility aligns with encouraging innovation from communities and institutions well-positioned to address inequities through improved data and methods.

What would a strong application generally need to show (based on the description provided)?

A strong application would clearly explain (1) what is genuinely new about the algorithm or method, (2) why it matters for cancer research (for example, enabling new science, improving decision-making, or addressing an unmet need), and (3) how feasibility will be demonstrated using relevant cancer data or use cases, including what success looks like for an exploratory R21 project.

What types of projects are implied to be a less ideal fit for this particular FOA?

Projects that are mainly later-stage technology efforts, such as turning an existing prototype into a hardened tool, adapting it for widespread use, or otherwise doing product-oriented development, are implied to be better suited to companion ITCR FOAs designed for downstream development.

What is the simplest one-line summary of the opportunity?

A targeted NCI ITCR R21 supporting early, high-impact algorithm and methods innovation for cancer research, with optional clinical trial involvement and a focus on demonstrating feasibility and cancer relevance.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Previous opportunity: Notice of Stakeholders Meeting on USAID/PEPFAR Strategic Plan for Strengthening Indigenous Partnerships

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 19 038

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 19 038) also looked into and applied for these:

Funding Opportunity
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 19 039

Funding Number: RFA CA 19 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 19 041

Funding Number: RFA CA 19 041
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 19 040

Funding Number: RFA CA 19 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed) Apply for RFA DA 19 037

Funding Number: RFA DA 19 037
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed) Apply for RFA DA 19 038

Funding Number: RFA DA 19 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) Apply for RFA DA 19 039

Funding Number: RFA DA 19 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 19 047

Funding Number: RFA CA 19 047
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 19 242

Funding Number: PAR 19 242
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed) Apply for PAR 19 246

Funding Number: PAR 19 246
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Limited Competition: Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional) Apply for PAR 19 256

Funding Number: PAR 19 256
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) Apply for PAR 19 258

Funding Number: PAR 19 258
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 19 259

Funding Number: PAR 19 259
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $10,000,000
Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed) Apply for RFA DA 20 005

Funding Number: RFA DA 20 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Apply for PAR 19 264

Funding Number: PAR 19 264
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 041

Funding Number: RFA AI 19 041
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Apply for PAR 19 277

Funding Number: PAR 19 277
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Blockchain Technology to Improve SUD Care (R43/R44 - Clinical Trial Optional) Apply for RFA DA 20 012

Funding Number: RFA DA 20 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Blockchain Technology to Improve SUD Care (R41/R42 - Clinical Trial Optional) Apply for RFA DA 20 011

Funding Number: RFA DA 20 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) Apply for PAR 19 278

Funding Number: PAR 19 278
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) Apply for PAR 19 279

Funding Number: PAR 19 279
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 19 038", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: